Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro (tirzepatide) can affect your menstrual cycle, and a late or irregular period is something a number of women report during the early weeks of treatment. Rapid weight loss and the hormonal shifts that accompany it are the most likely reason — the mechanism is biological, not a sign that something has gone wrong. That said, Mounjaro is a prescription-only medicine requiring ongoing clinical oversight, and any change in your cycle worth worrying about should be discussed with your prescriber rather than guessed at.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Body fat is not passive tissue. It produces and converts oestrogens, and the pace at which fat mass changes can shake the hormonal balance that governs ovulation. When you lose weight quickly (which is exactly what tirzepatide can produce) levels of oestrogen, leptin and other reproductive hormones shift, sometimes enough to delay or even temporarily skip a period.
This is the same mechanism behind cycle disruption in people who lose weight through surgery or intensive dietary intervention. Mounjaro is doing something similar at a biological level: appetite falls sharply, energy intake drops, and the body recalibrates. A late period in this context is usually the cycle adjusting rather than a sign of an underlying problem.
A question our prescribers hear most weeks is whether Mounjaro itself directly causes menstrual changes. The short answer is that the medicine's own pharmacological action on the uterus or ovaries is not established; what is well-documented is the downstream effect of the weight loss it drives. The NHS tirzepatide patient guide does not list irregular periods as a direct side effect, which places this squarely in the territory of weight-change physiology rather than drug toxicity.
Possibly, and this matters more than it might seem at first. Weight loss itself can temporarily increase fertility in some people with conditions such as polycystic ovary syndrome, where excess weight suppresses ovulation. So the same treatment that might delay one period could, in certain circumstances, make conception more likely than it was before.
Mounjaro is not recommended during pregnancy. If your period is late and there is any chance of pregnancy, take a test before drawing any other conclusions. Do not wait to see whether the next cycle arrives.
There is also the contraception angle worth knowing about. The NHS England guidance on weight-management injections is specific: because tirzepatide slows gastric emptying, absorption of the oral contraceptive pill may be reduced for the first four weeks of treatment and for four weeks after each dose increase. Adding a non-oral method (condoms, for example) during those windows is the standard advice. If you are already thinking about taking Mounjaro alongside your cycle, this is worth raising at your consultation.
One delayed cycle, especially early in treatment when weight loss tends to be fastest, is unlikely to signal anything serious. Patterns are different. If your periods have become consistently irregular, very light, very heavy, or have stopped for more than two or three cycles, that needs proper clinical assessment, not reassurance from an online article.
The same applies if you develop pelvic pain, unusual discharge, or any symptom that sits alongside the cycle change rather than replacing it. Those are reasons to contact your GP or prescriber promptly, independent of your Mounjaro treatment.
If you want to explore what a late period on Mounjaro actually means for your situation, or you're wondering whether Mounjaro can stop periods entirely, we've answered both questions in detail. And if you have a broader question about how Mounjaro affects periods generally, that page covers the wider picture.
For most people, yes. Once weight loss stabilises and the body adjusts to its new hormonal set point, cycles often regularise. The early months of treatment tend to be when disruption is most noticeable; this mirrors what is seen with other significant weight-loss interventions.
Practically, keeping a note of your cycle dates during treatment is useful, not obsessively, but enough to spot a pattern if one develops. Eating sufficient protein and maintaining muscle through some resistance activity both matter during rapid weight loss, not just for body composition but for hormonal resilience. Your prescriber can discuss whether any specific monitoring makes sense for your circumstances.
Mounjaro is available through a private prescription following clinical assessment. If you're considering starting treatment, or you have questions about how it might interact with your reproductive health, you can speak to our prescribers through a free consultation. Every consultation at nume is reviewed the same day by a real GPhC-registered prescriber, someone who can factor in your full picture, including your cycle history. For wider context on the treatment itself, the Mounjaro overview covers how it works, what to expect, and how to access it safely. There is also evidence that Mounjaro may trigger a period in some people, a related but distinct question covered separately.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.